PATENTS RELATED TO MALARIA

Although Dr. Demchick also represents patent seekers with non-microbiological inventions, his doctorate is in microbiology. Microbiology has been the primary focus of his research and teaching. He especially loves dealing with patent searches and applications for involving microbiology.

Dr. Demchick is a scientist with a quarter of a century of research experience in academic, industrial and governmental settings.

If you are considering patent protection for an invention, Dr. Demchick will be glad to discuss the matter with you. There is no charge for an initial discussion.

The following sampling is to give you some sense of the types of malaria related inventions which have received United States patent protection. The patent list is not exhaustive and is certainly not a substitute for a proper patent search . It should be noted that only U.S. Patents are included.

It should be noted that spelling, form and typographical errors in the original patents are preserved here.

Anti-malarial compounds (United States Patent 7,132,431)

Malaria polypeptides (United States Patent 7,125,958)

Live genetically attenuated malaria vaccine (United States Patent 7,122,179)

Synthetic genes for malarial proteins and methods of use (United States Patent 7,078,507)

Malaria vaccine (United States Patent 7,078,043)

Malarial pre-erythrocytic stage polypeptide molecules (United States Patent 7,056,518)

Inactivation of West Nile virus and malaria using photosensitizers (United States Patent 7,049,110)

Plasmodium falciparum merozoite surface protein-1 malaria produced in transgenic plants (United States Patent 7,037,681)

Malaria immunogen and vaccine (United States Patent 6,942,866)

Compositions for treating or preventing malaria and method of treating malaria (United States Patent 6,939,892)

Recombinants process for preparing a complete malaria antigen, gp190/MSP1 (United States Patent 6,933,130)

Recombinant multivalent malarial vaccine against Plasmodium falciparum (United States Patent 6,828,416)

Transmission blocking immunogen from malaria (United States Patent 6,780,417)

Compositions comprised of antigenic factors associated with malaria parasites, and process for making same (United States Patent 6,716,590)

Anti-malarial compounds, compositions and methods (United States Patent 6,689,777)

Universal T-cell epitopes for anti-malarial vaccines (United States Patent 6,669,945)

Use of (+)mefloquine for the treatment of malaria (United States Patent 6,664,397)

Malaria immunogenic composition (United States Patent 6,660,498)

Treatment of malaria with farnesyl protein transferase inhibitors (United States Patent 6,645,966)

Process for insecticidal formulation effective in controlling malarial vector, mosquitoes (United States Patent 6,623,766)

Malaria vaccine (United States Patent 6,579,524)

Uses for anti-malarial therapeutic agents (United States Patent 6,572,858)

Malaria vaccine based upon the addition of a MSA1 peptide (United States Patent 6,551,586)

Indolo[2,1-b] quinazole-6, 12-dione antimalarial compounds and methods of treating malaria therewith (United States Patent 6,531,487)

Use of tetrandrine and its derivatives to treat malaria (United States Patent 6,528,519)

Process for the preparation of anti-malarial drugs (United States Patent 6,479,660)

Malaria merozoite antigen subunit vaccine (United States Patent 6,417,341)

Combination preparation for treating malaria (United States Patent 6,413,993)

Murine monoclonal antibody protective against Plasmodium vivax malaria (United States Patent 6,399,062)

Selective lysis of malaria infected erythrocytes (United States Patent 6,384,015)

Process for the preparation of a formulation of dihydroartemisinin for the control of wide spectrum of malaria (United States Patent 6,362,219)

Synergistic anti-malarial formulation (United States Patent 6,326,023)

Indolo[2,1-B] quinazole-6,12-dione antimalarial compounds and methods of treating malaria therewith (United States Patent 6,284,772)

Method of screening for anti-malarial compounds (United States Patent 6,268,160)

Formulation of dihydroartemisinin for the control of wide spectrum of malaria (United States Patent 6,214,864)

Malaria recombinant poxvirus vaccine (United States Patent 6,214,353)

Malarial pre-erythrocytic stage polypeptide molecules (United States Patent 6,191,270)

Anti-malarial composition and method of use (United States Patent 6,159,953)

Vaccine for induction of immunity to malaria (United States Patent 6,093,406)

Method for production of Plasmodium causing relapsing malaria (United States Patent 6,090,614)

.beta.-Alkoxyacrylates against malaria (United States Patent 6,084,120)

Polynucleotide vaccine protective against malaria, methods of protection and vector for delivering polynucleotide vaccines (United States Patent 6,066,623)

Halofantrine free base for the treatment of malaria and compositions (United States Patent 5,968,987)

Quinoline derivatives for treating malaria (United States Patent 5,948,791)

Malarial binding site in duffy blood group protein (United States Patent 5,911,991)

Method of treatment for malaria utilizing serotonin receptor ligands (United States Patent 5,874,477)

Transmission-blocking vaccine against malaria (United States Patent 5,853,739)

Rapid detection and drug sensitivity of malaria (United States Patent 5,827,681)

Protective 17 KDA malaria hepatic and erythrocytic stage immunogen and gene (United States Patent 5,814,617)

Detection of malaria (United States Patent 5,792,609)

Malaria recombinant poxviruses (United States Patent 5,766,597)

Malaria recombinant poxvirus (United States Patent 5,756,101)

Use of colloidal silica for the treatment of sickle-cell anaemia, malaria and exogenously induced leucopenias (United States Patent 5,753,632)

Target antigens of transmission blocking antibodies for malaria parasites (United States Patent 5,753,238)

Malaria treatments (United States Patent 5,726,166)

Malaria vaccine (United States Patent 5,720,959)

Method of treating malaria with desbutylhalofantrine (United States Patent 5,711,966)

Polypeptides and DNA encoding same, associated with human malaria parasites (United States Patent 5,695,957)

Distamycin a derivatives as anti-malarial agents (United States Patent 5,670,534)

Method reducing TNF-alpha in mammals with cerebral malaria (United States Patent 5,624,913)

Antiparasitic oligonucleotides active against drug resistant malaria (United States Patent 5,616,564)

Methods for treating malaria and other diseases (United States Patent 5,604,258)

Cloning of a malarial gene (United States Patent 5,597,708)

Method of treating chloroquine-resistant malaria with aminoquinoline derivatives (United States Patent 5,596,002)

Malaria-specific DNA sequences, expression products thereof, and the use thereof (United States Patent 5,585,268)

Target antigens of transmission blocking antibodies for malaria parasites (United States Patent 5,527,700)

Bisquinolines and processes for their production and use to treat malaria (United States Patent 5,510,356)

Fractionated heparin for the therapeutic treatment of malaria (United States Patent 5,472,953)

Reagent for detecting malaria infected cells and a detecting method for malaria infected cells using the same (United States Patent 5,470,751)

Iloprost with action against cerebral malaria (United States Patent 5,466,713)

Synthetic malarial antigens and uses thereof (United States Patent 5,456,911)

Protective Plasmodium falciparum hybrid proteins which contain part-sequences of the malaria antigens HRPII and SERP, the preparation and use thereof (United States Patent 5,395,614)

Despiramine in the treatment of drug-resistant malarial infections (United States Patent 5,373,005)

Compound and method of treatment for falciparum malaria (United States Patent 5,362,726)

Use of interferon and a substance with an antimalarial activity for the treatment of malaria infections (United States Patent 5,270,037)

Malaria antigen (United States Patent 5,231,168)

Process for preparing a vaccine against malaria (United States Patent 5,229,110)

Recombinant malarial polypeptides (United States Patent 5,225,534)

Polypeptide useful for the preparation of antimalarial vaccines and of diagnostic kits for the detection of malarial affections (United States Patent 5,225,530)

Use of triazine and pyrimidine compounds for obtaining medicaments that reverse resistance to anti-cancer and anti-malarial agents (United States Patent 5,225,405)

Pharmaceutical combination for the prophylaxis and therapy of malaria (United States Patent 5,219,865)

Method for preventing malaria (United States Patent 5,216,004)

Esters of castanospermine in the treatment of cerebral malaria (United States Patent 5,214,050)

Method for the treatment of malaria (United States Patent 5,206,236)

Protective malaria sporozoite surface protein immunogen and gene (United States Patent 5,198,535)

Malaria-specific DNA sequences, expression products thereof, and the use thereof (United States Patent 5,194,587)

Method for diagnosing malaria (United States Patent 5,124,141)

Vaccines for the malaria circumsporozoite protein (United States Patent 5,112,749)

New compounds which are active against the tissue forms of malaria and method of preparation (United States Patent 5,110,935)

5-(phenylalkoxy)primaquine and 5[(heterocycle)alkoxy] primaquine compounds and their use for treatment of malaria (United States Patent 5,104,885)

Antibodies for providing protection against P. vivax malaria infection (United States Patent 5,101,017)

Protective four amino acid epitope against Plasmodium vivax malaria (United States Patent 5,095,093)

Recombinant malarial polypeptides (United States Patent 5,061,788)

Polypeptidic fractions inducing protective antibodies against malaria parasites and immunogenic compositions (United States Patent 5,032,397)

Synthetic vaccine against P. falciparum malaria (United States Patent 5,028,425)

Use of tetrandrine and its derivatives to treat malaria (United States Patent 5,025,020)

Deoxoartemisinin: new compound and composition for the treatment of malaria (United States Patent 5,023,353)

Method of traeting malaria with cyproheptadine derivatives (United States Patent 5,021,426)

Monoclonal antibodies to a pan-malarial antigen (United States Patent 5,001,225)

Vaccine against the sporozoite stage of malaria (United States Patent 4,997,647)

Anti-malarial compounds (United States Patent 7,132,431)

Malaria polypeptides (United States Patent 7,125,958)

Live genetically attenuated malaria vaccine (United States Patent 7,122,179)

Synthetic genes for malarial proteins and methods of use (United States Patent 7,078,507)

Malaria vaccine (United States Patent 7,078,043)

Malarial pre-erythrocytic stage polypeptide molecules (United States Patent 7,056,518)

Inactivation of West Nile virus and malaria using photosensitizers (United States Patent 7,049,110)

Plasmodium falciparum merozoite surface protein-1 malaria produced in transgenic plants (United States Patent 7,037,681)

Malaria immunogen and vaccine (United States Patent 6,942,866)

Compositions for treating or preventing malaria and method of treating malaria (United States Patent 6,939,892)

Recombinants process for preparing a complete malaria antigen, gp190/MSP1 (United States Patent 6,933,130)

Recombinant multivalent malarial vaccine against Plasmodium falciparum (United States Patent 6,828,416)

Transmission blocking immunogen from malaria (United States Patent 6,780,417)

Compositions comprised of antigenic factors associated with malaria parasites, and process for making same (United States Patent 6,716,590)

Anti-malarial compounds, compositions and methods (United States Patent 6,689,777)

Universal T-cell epitopes for anti-malarial vaccines (United States Patent 6,669,945)

Use of (+)mefloquine for the treatment of malaria (United States Patent 6,664,397)

Malaria immunogenic composition (United States Patent 6,660,498)

Treatment of malaria with farnesyl protein transferase inhibitors (United States Patent 6,645,966)

Process for insecticidal formulation effective in controlling malarial vector, mosquitoes (United States Patent 6,623,766)

Malaria vaccine (United States Patent 6,579,524)

Uses for anti-malarial therapeutic agents (United States Patent 6,572,858)

Malaria vaccine based upon the addition of a MSA1 peptide (United States Patent 6,551,586)

Indolo[2,1-b] quinazole-6, 12-dione antimalarial compounds and methods of treating malaria therewith (United States Patent 6,531,487)

Use of tetrandrine and its derivatives to treat malaria (United States Patent 6,528,519)

Process for the preparation of anti-malarial drugs (United States Patent 6,479,660)

Malaria merozoite antigen subunit vaccine (United States Patent 6,417,341)

Combination preparation for treating malaria (United States Patent 6,413,993)

Murine monoclonal antibody protective against Plasmodium vivax malaria (United States Patent 6,399,062)

Selective lysis of malaria infected erythrocytes (United States Patent 6,384,015)

Process for the preparation of a formulation of dihydroartemisinin for the control of wide spectrum of malaria (United States Patent 6,362,219)

Synergistic anti-malarial formulation (United States Patent 6,326,023)

Indolo[2,1-B] quinazole-6,12-dione antimalarial compounds and methods of treating malaria therewith (United States Patent 6,284,772)

Method of screening for anti-malarial compounds (United States Patent 6,268,160)

Formulation of dihydroartemisinin for the control of wide spectrum of malaria (United States Patent 6,214,864)

Malaria recombinant poxvirus vaccine (United States Patent 6,214,353)

Malarial pre-erythrocytic stage polypeptide molecules (United States Patent 6,191,270)

Anti-malarial composition and method of use (United States Patent 6,159,953)

Vaccine for induction of immunity to malaria (United States Patent 6,093,406)

Method for production of Plasmodium causing relapsing malaria (United States Patent 6,090,614)

.beta.-Alkoxyacrylates against malaria (United States Patent 6,084,120)

Polynucleotide vaccine protective against malaria, methods of protection and vector for delivering polynucleotide vaccines (United States Patent 6,066,623)

Halofantrine free base for the treatment of malaria and compositions (United States Patent 5,968,987)

Quinoline derivatives for treating malaria (United States Patent 5,948,791)

Malarial binding site in duffy blood group protein (United States Patent 5,911,991)

Method of treatment for malaria utilizing serotonin receptor ligands (United States Patent 5,874,477)

Transmission-blocking vaccine against malaria (United States Patent 5,853,739)

Rapid detection and drug sensitivity of malaria (United States Patent 5,827,681)

Protective 17 KDA malaria hepatic and erythrocytic stage immunogen and gene (United States Patent 5,814,617)

Detection of malaria (United States Patent 5,792,609)

Malaria recombinant poxviruses (United States Patent 5,766,597)

Malaria recombinant poxvirus (United States Patent 5,756,101)

Use of colloidal silica for the treatment of sickle-cell anaemia, malaria and exogenously induced leucopenias (United States Patent 5,753,632)

Target antigens of transmission blocking antibodies for malaria parasites (United States Patent 5,753,238)

Malaria treatments (United States Patent 5,726,166)

Malaria vaccine (United States Patent 5,720,959)

Method of treating malaria with desbutylhalofantrine (United States Patent 5,711,966)

Polypeptides and DNA encoding same, associated with human malaria parasites (United States Patent 5,695,957)

Distamycin a derivatives as anti-malarial agents (United States Patent 5,670,534)

Method reducing TNF-alpha in mammals with cerebral malaria (United States Patent 5,624,913)

Antiparasitic oligonucleotides active against drug resistant malaria (United States Patent 5,616,564)

Methods for treating malaria and other diseases (United States Patent 5,604,258)

Cloning of a malarial gene (United States Patent 5,597,708)

Method of treating chloroquine-resistant malaria with aminoquinoline derivatives (United States Patent 5,596,002)

Malaria-specific DNA sequences, expression products thereof, and the use thereof (United States Patent 5,585,268)

Target antigens of transmission blocking antibodies for malaria parasites (United States Patent 5,527,700)

Bisquinolines and processes for their production and use to treat malaria (United States Patent 5,510,356)

Fractionated heparin for the therapeutic treatment of malaria (United States Patent 5,472,953)

Reagent for detecting malaria infected cells and a detecting method for malaria infected cells using the same (United States Patent 5,470,751)

Iloprost with action against cerebral malaria (United States Patent 5,466,713)

Synthetic malarial antigens and uses thereof (United States Patent 5,456,911)

Protective Plasmodium falciparum hybrid proteins which contain part-sequences of the malaria antigens HRPII and SERP, the preparation and use thereof (United States Patent 5,395,614)

Despiramine in the treatment of drug-resistant malarial infections (United States Patent 5,373,005)

Compound and method of treatment for falciparum malaria (United States Patent 5,362,726)

Use of interferon and a substance with an antimalarial activity for the treatment of malaria infections (United States Patent 5,270,037)

Malaria antigen (United States Patent 5,231,168)

Process for preparing a vaccine against malaria (United States Patent 5,229,110)

Recombinant malarial polypeptides (United States Patent 5,225,534)

Polypeptide useful for the preparation of antimalarial vaccines and of diagnostic kits for the detection of malarial affections (United States Patent 5,225,530)

Use of triazine and pyrimidine compounds for obtaining medicaments that reverse resistance to anti-cancer and anti-malarial agents (United States Patent 5,225,405)

Pharmaceutical combination for the prophylaxis and therapy of malaria (United States Patent 5,219,865)

Method for preventing malaria (United States Patent 5,216,004)

Esters of castanospermine in the treatment of cerebral malaria (United States Patent 5,214,050)

Method for the treatment of malaria (United States Patent 5,206,236)

Protective malaria sporozoite surface protein immunogen and gene (United States Patent 5,198,535)

Malaria-specific DNA sequences, expression products thereof, and the use thereof (United States Patent 5,194,587)

Method for diagnosing malaria (United States Patent 5,124,141)

Vaccines for the malaria circumsporozoite protein (United States Patent 5,112,749)

New compounds which are active against the tissue forms of malaria and method of preparation (United States Patent 5,110,935)

5-(phenylalkoxy)primaquine and 5[(heterocycle)alkoxy] primaquine compounds and their use for treatment of malaria (United States Patent 5,104,885)

Antibodies for providing protection against P. vivax malaria infection (United States Patent 5,101,017)

Protective four amino acid epitope against Plasmodium vivax malaria (United States Patent 5,095,093)

Recombinant malarial polypeptides (United States Patent 5,061,788)

Polypeptidic fractions inducing protective antibodies against malaria parasites and immunogenic compositions (United States Patent 5,032,397)

Synthetic vaccine against P. falciparum malaria (United States Patent 5,028,425)

Use of tetrandrine and its derivatives to treat malaria (United States Patent 5,025,020)

Deoxoartemisinin: new compound and composition for the treatment of malaria (United States Patent 5,023,353)

Method of traeting malaria with cyproheptadine derivatives (United States Patent 5,021,426)

Monoclonal antibodies to a pan-malarial antigen (United States Patent 5,001,225)

Vaccine against the sporozoite stage of malaria (United States Patent 4,997,647)

Although his recognition as a registered patent agent permits him to represent others in all patent matters before the United States Patent and Trademark Office, Dr. Demchick limits his practice to patent matters involving inventions for which he is confident that his expertise will allow him to serve his client well. He will gladly discuss whether he is comfortable handling cases involving inventions in a particular field. He will err on the side of declining cases if he has uncertainty about his ability to do what is needed in the case. Dr. Demchick does not represent clients in court. However, he refers clients to a patent attorney who does represent others in court, if it appears likely that patent related representation in court is appropriate. Dr. Demchick prepares and files non-provisional (regular) patent applications and provisional patent applications. He prepares and files utility patent applications and design patent applications. He prepares and files U.S. patent applications and international patent applications under the Patent Cooperation Treaty (PCT). He prepares and files applications to enter the U.S. National Phase for inventions for which international patent applications (PCT) were already filed. One of the matters he discusses with each client or potential client is which type of application(s) best meets that client's needs. He usually does a patent search (patentability search) as part of the preparation of a patent application. He discusses the value of patent searching with each inventor before agreeing to prepare a patent application for that inventor.